APA (7th ed.) Citation

P, M., CK, T., P, M., JS, N., MA, T., TA, M., . . . A, S. (2025). Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices. JACC. Heart failure, 13(11), 102573. https://doi.org/10.1016/j.jchf.2025.102573

Chicago Style (17th ed.) Citation

P, Marques, Travlos CK, Matias P, Neves JS, Tsoukas MA, Mavrakanas TA, Joza J, Ferreira JP, and Sharma A. "Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices." JACC. Heart Failure 13, no. 11 (2025): 102573. https://doi.org/10.1016/j.jchf.2025.102573.

MLA (9th ed.) Citation

P, Marques, et al. "Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices." JACC. Heart Failure, vol. 13, no. 11, 2025, p. 102573, https://doi.org/10.1016/j.jchf.2025.102573.